Capital Reallocation on the Fringes: Signals of Strategic PivotsGlobal Report·Jul 26 at 04:14 AMGNRC-0.21%BWEN-12.09%
The Fragmentation of Innovation: Why Niche Markets Matter This SummerGlobal Report·Jul 25 at 04:13 AMSTDN-2.79%CAPR0.00%
Capital Allocation Signals: Mid-Cap Firms Pivot to Strategic ConsolidationGlobal Report·Jul 24 at 04:12 AMJSPR-5.20%NOVT-2.72%
U.S. stock night trading volatility: Jasper Therapeutics fell 3% in after-hours trading, with executives disclosing their holdings intensively attracting attentionPrice Alert·Jul 23 at 07:31 PMJSPR-5.20%
Jasper Therapeutics names Greg Keenan as chief medical officer in initial beneficial ownership filingPUBT·Jul 23 at 03:01 PMJSPR-5.20%
U.S. stock night trading volatility: Jasper Therapeutics fell 3.93% in after-hours trading, with executive sell-offs and positive cooperation failing to mask market concernsPrice Alert·Jul 22 at 11:46 PMJSPR-5.20%
Jasper Therapeutics COO Matthew E. Ros files initial beneficial ownership statementPUBT·Jul 22 at 06:11 PMJSPR-5.20%
Chime's Expansion and Jasper's M&A Deal Highlight Micro-Catalyst Driven US MarketGlobal Report·Jul 22 at 04:17 AMCHYM+0.22%ALLY-2.63%
Pre-market hot trades in US stocks: Jasper Therapeutics pre-market down 4.18%; Salesforce pre-market down 3.64%Price Alert·Jul 21 at 06:22 AMJSPR-5.20%CRM+3.79%
Jasper Therapeutics director Patrick J. Crutcher files initial beneficial ownership statementPUBT·Jul 20 at 07:38 PMJSPR-5.20%
12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga_article·Jul 17 at 12:05 PMAPLM-4.06%APLMW-4.04%
Jasper Completes Kira Acquisition, Raises $132M PIPE and Licenses C5a Programs to MiradorTradingView·Jul 17 at 05:13 AMJSPR-5.20%
